CRISPR/Cas-gemedieerde gen manipulatie en de potentiële toepassing voor hematologische stoornissen

Translated title of the contribution: CRISPR/Cas-mediated gene editing and the potential application in hematological disease

T. Csikós, RWJ Groen

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

If there is one discipline in the clinic which will profitfrom the recent major advances made in gene modificationtechnologies, it must be hematology, sincemany hematological disorders are based on welldescribed aberrations in the human genome. In thisreview we describe CRISPR/Cas and the inroads it ismaking in hematology-based research; developmentswhich might lead to gene therapy.
Original languageDutch
Pages (from-to)29-38
JournalNederlands Tijdschrift voor Hematologie
Volume2017
Issue number14
Publication statusPublished - Jan 2017

Cite this